Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT03939416
Other study ID # Pold-fibromyalgia-udl
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date March 30, 2025

Study information

Verified date March 2024
Source Omphis Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical research aims to study the effects of the introduction of POLD manual therapy within the protocol of fibromyalgia


Description:

This research project aims to generate scientific evidence on the clinical results obtained in the treatment of fibromyalgia, which usually presents with pain and long-term disability, by applying a special form of manual physiotherapy called "POLD concept". This therapy is based on a passive, oscillatory mobilization, performed at a resonance frequency and applied throughout the time of the therapeutic session, on the vertebrae and the muscles of the back, without interruption. It is carried out on the initiative of the research team in "pain treatment", of the physiotherapy school of the University of Lleida, in collaboration with the Omphis Foundation and the clinical service of the Unity of Fibromyalgia of GSS (Hospital Universitarios de Santa MarĂ­a, Lleida)


Recruitment information / eligibility

Status Suspended
Enrollment 50
Est. completion date March 30, 2025
Est. primary completion date December 30, 2024
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria: 1. Patients diagnosed with Fibromyalgia 2. Patients over 25 years old and up to 65 years old, regardless of whether they are women or men. 3. Patients who present pain with a minimum value of 5 on the numerical pain scale from 0 to 10, at the time of beginning the study. 4. Presence of these symptoms in a long period (more than 6 months) Exclusion Criteria: 1. Patients with a recent traumatic history. 2. Presence of an irradiation component of neurological origin to upper or lower limbs 3. Patients with neurological alterations, both central and peripheral. 4. Patients who are taking opioid-based analgesic medication. 5. Patients with severe spinal malformations. 6. That they are following any other type of treatment, whether manual or physical agents or alternative or complementary therapies. 7. That they have been treated with infiltrations or similar in a period of less than one year before beginning the study. 8. Patients with a serious psychiatric history such as schizophrenia or psychopathies. 9. Patients who have vestibular problems that do not tolerate oscillation. 10. Patients with heart failure 11. Existence of judicial process of disability

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Experimental
STANDART Physical exercise: degreed joint mobilization, self muscle elongation and postural correction. Sophrology: mental control of insomnia and painful perception Cognitive behavioral therapy: analysis of non-assertive relationship patterns or dependence, dysfunctional beliefs, as well as their consequences, psychoeducation of the disease. Strategies for pain management, anxiety, assertiveness and acceptance of the disease POLD Rhythmic transversal muscle mobilization in posterior chain musculature. General vertebral decompression from the sacrum and pelvis Metameric subcutaneous mobilization Rhythmic vertebral mobilization from the spinous processes.
Control
STANDART Physical exercise: degreed joint mobilization, self muscle elongation and postural correction. Sophrology: mental control of insomnia and painful perception Cognitive behavioral therapy: analysis of non-assertive relationship patterns or dependence, dysfunctional beliefs, as well as their consequences, psychoeducation of the disease. Strategies for pain management, anxiety, assertiveness and acceptance of the disease

Locations

Country Name City State
Spain Specialized hospital unit of fibromyalgia and SD of conical fatigue of L'Hospital Universitari de Santa María (GSS) Lleida Catalonia

Sponsors (2)

Lead Sponsor Collaborator
Omphis Foundation Universitat de Lleida

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Demographic data The following data will be recorded: age, sex, race, children, study start date and final date. Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
Primary Level of Pain: VAS We will use the Visual Analog Pain Scale (VAS), consisting of a line of 10 cm, whose left end coincides with the value 0 (absence of pain) and the right end with the value 10 (maximum pain imaginable), without reference marks intemediate The patient will mark a point in the line corresponding to his pain at the time of the test, the measurement of the centimeters from the left edge will indicate the analogical score of his pain between 0 and 10. Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
Primary Quality of pain: The Mc Gill pain questionnaire The Mc Gill pain questionnaire comprises 62 descriptors distributed in 15 classes and, in turn, in 3 dimensions (sensory, affective and evaluative).
A value of pain is obtained for each dimension: sensory pain intensity (VID (S), affective pain intensity (VID (A)) and evaluative pain intensity (VID (E)) The sensory component is evaluated in 7 subclasses. The patient mark one or no descriptor of each subclass, if he scores 1 he scores 1 and if he does not mark none he scores 0. The score of the VID (S) is obtained adding and will be, therefore, between 0 and 7. The affective dimension includes subclasses 8 to 13 and its score ranges from 0 to 6. The evaluative dimension corresponds to subclass 14 and the score of it will be 0 or 1. From the sum of the three, the total score (VID (T)) is obtained, from 0 to 14. In addition, the current pain intensity (VIA) is scored from subclass 15, the score is 0-no pain, 1-mild, 2-annoying, 3-intense, 4-strong, 5-unbearable.
Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
Primary Pain interference: We use the Brief Pain Inventory We use the Brief Pain Inventory that gives two main scores: a pain severity score and a pain interference score. The pain severity score is calculated from the four items about pain intensity. Each item is rated from 0, no pain, to 10, pain as bad as you can imagine, and contributes with the same weight to the final score, ranging from 0 to 40. The pain interference score corresponds to the item on pain interference. The seven sub items are rated from 0, does not interfere, to 10, completely interferes, and contributes with the same weight to the final score, ranging from 0 to 70. The first item, pain drawing diagrams (painful and most painful areas) do not contribute to the scoring Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05659862 - Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT03042728 - Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program N/A
Recruiting NCT06097091 - Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia N/A
Recruiting NCT04554784 - Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia N/A
Completed NCT03300635 - Metabolism, Muscle Function and Psychological Factors in Fibromyalgia N/A
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT03227952 - Sensory Stimulation in Fibromyalgia N/A
Completed NCT03166995 - Postural Exercises in Women With Fibromyalgia N/A
Recruiting NCT06237595 - Vagus Nerve Stimulation in Fibromyalgia N/A
Completed NCT01888640 - Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST) N/A
Completed NCT03641495 - Pain Education and Therapeutic Exercise for Fibromyalgia N/A
Recruiting NCT05581628 - FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
Active, not recruiting NCT05128162 - Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia Phase 2
Completed NCT04674878 - Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia N/A
Active, not recruiting NCT04084795 - Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia N/A
Completed NCT03129906 - Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients N/A
Completed NCT05058911 - Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia N/A
Recruiting NCT04571528 - Effectiveness of VIRTUAL FIBROWALK STUDY N/A
Recruiting NCT04571853 - New Educational Tool for FM N/A